source
- FDA appoints permanent heads of CDER and CBER, adding AI deputy roleThe Trump administration announced permanent appointments to two key FDA centers after a period of turnover. Michael Davis, who had been acting director of the Center for Drug Evaluation and Resea…
- nPhase unveils AI-driven clinical data platform to accelerate trial design and submissionnPhase, a clinical research organization, announced the launch of an end-to-end platform called nPhase.ai that uses artificial intelligence to manage clinical trial data. The platform includes a S…